November 6, 2018 2:07pm

Ionis Pharmaceuticals (IONS) jumped +$0.35 or +0.68% to $51.87 after reporting a net loss of -$4.6 M or -$0.03 per share beating “street” expectation of a loss of -$0.13 while posting revenue of $145.4 M versus the estimate of $132.4 M.

UniQure NV (QURE) jumped +$0.549 or +1.91% to $26.09 after reporting a net loss of $22 M or -$0.59 per share. The results topped “street” expectations for a loss of -$0.63 per share although revenue of $3.1 M fell short of forecast of $3.4 M.

Spark Therapeutics (ONCE) drops -$2.43 or -5.52% to $41.54 after reporting a Q3 loss of $47.4 M or -$1.26 per share, miss’s revenue “street” expectation. (ONCE’s results fell short of “street” expectations for a loss of $1.04 per share with revenue of $10.7 M, also falling short having expected $26.1 M.

Vericel (VCEL) jumps +$5.25 or +45.49% to $16.79 post “earnings” release while recording record revenue but, still with a net loss of $1.1 M or $0.02 loss per share, compared to net loss of $5.4 M, or $0.16 per share, in Q3/17.


Members only. Please login.